4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-044533
CEO and President gave up 7,177 shares (to pay taxes)
- CEO and President acquired 14,572 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kendall Keith J · CEO and President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-30 | Exercise or conversion : show line 1 in the form | +14,572 | 635,711 | D | ||
| 2018-11-30 | Shares withheld for taxes : show line 2 in the form | −7,177 | $8.59 | $61,650 | 628,534 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-11-30 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −14,572 | 87,432 | D |
Loading xslF345X03/form4.xml…